124 related articles for article (PubMed ID: 11033448)
1. Development and evaluation of C-telopeptide enzyme-linked immunoassay for measurement of bone resorption in mouse serum.
Srivastava AK; Bhattacharyya S; Castillo G; Miyakoshi N; Mohan S; Baylink DJ
Bone; 2000 Oct; 27(4):529-33. PubMed ID: 11033448
[TBL] [Abstract][Full Text] [Related]
2. Development and application of a serum C-telopeptide and osteocalcin assay to measure bone turnover in an ovariectomized rat model.
Srivastava AK; Bhattacharyya S; Castillo G; Wergedal J; Mohan S; Baylink DJ
Calcif Tissue Int; 2000 Jun; 66(6):435-42. PubMed ID: 10821880
[TBL] [Abstract][Full Text] [Related]
3. A new monoclonal antibody ELISA for detection and characterization of C-telopeptide fragments of type I collagen in urine.
Srivastava AK; MacFarlane G; Srivastava VP; Mohan S; Baylink DJ
Calcif Tissue Int; 2001 Dec; 69(6):327-36. PubMed ID: 11800229
[TBL] [Abstract][Full Text] [Related]
4. Development of a synthetic peptide-based tartrate-resistant acid phosphatase radioimmunoassay for the measurement of bone resorption in rat serum.
Srivastava AK; Libanati C; Lane N; Baylink DJ
J Bone Miner Metab; 2002; 20(2):66-72. PubMed ID: 11862527
[TBL] [Abstract][Full Text] [Related]
5. Development and application of a synthetic peptide-based osteocalcin assay for the measurement of bone formation in mouse serum.
Srivastava AK; Castillo G; Wergedal JE; Mohan S; Baylink DJ
Calcif Tissue Int; 2000 Sep; 67(3):255-9. PubMed ID: 10954781
[TBL] [Abstract][Full Text] [Related]
6. Development of a monoclonal antibody to urinary degradation products from the C-terminal telopeptide alpha 1 chain of type I collagen. Application in an enzyme immunoassay and comparison to CrossLaps ELISA.
Fledelius C; Kolding I; Qvist P; Bonde M; Hassager C; Reginster JY; Hejgaard J; Frøokiaer H; Christiansen C
Scand J Clin Lab Invest; 1997 Feb; 57(1):73-83. PubMed ID: 9127460
[TBL] [Abstract][Full Text] [Related]
7. Measurement of bone degradation products in serum using antibodies reactive with an isomerized form of an 8 amino acid sequence of the C-telopeptide of type I collagen.
Bonde M; Garnero P; Fledelius C; Qvist P; Delmas PD; Christiansen C
J Bone Miner Res; 1997 Jul; 12(7):1028-34. PubMed ID: 9200001
[TBL] [Abstract][Full Text] [Related]
8. An immunoassay for type I collagen alpha 1 helicoidal peptide 620-633, a new marker of bone resorption in osteoporosis.
Garnero P; Delmas PD
Bone; 2003 Jan; 32(1):20-6. PubMed ID: 12584032
[TBL] [Abstract][Full Text] [Related]
9. Short-term changes in serum PINP predict long-term changes in trabecular bone in the rat ovariectomy model.
Rissanen JP; Suominen MI; Peng Z; Morko J; Rasi S; Risteli J; Halleen JM
Calcif Tissue Int; 2008 Feb; 82(2):155-61. PubMed ID: 18219436
[TBL] [Abstract][Full Text] [Related]
10. Collagen type II C-telopeptide fragments as an index of cartilage degradation.
Christgau S; Garnero P; Fledelius C; Moniz C; Ensig M; Gineyts E; Rosenquist C; Qvist P
Bone; 2001 Sep; 29(3):209-15. PubMed ID: 11557363
[TBL] [Abstract][Full Text] [Related]
11. A urine midmolecule osteocalcin assay shows higher discriminatory power than a serum midmolecule osteocalcin assay during short-term alendronate treatment of osteoporotic patients.
Srivastava AK; Mohan S; Singer FR; Baylink DJ
Bone; 2002 Jul; 31(1):62-9. PubMed ID: 12110414
[TBL] [Abstract][Full Text] [Related]
12. The selective cyclooxygenase-2 inhibitor celecoxib reduces bone resorption, but not bone formation, in ovariectomized mice in vivo.
Kasukawa Y; Miyakoshi N; Srivastava AK; Nozaka K; Maekawa S; Baylink DJ; Mohan S; Itoi E
Tohoku J Exp Med; 2007 Mar; 211(3):275-83. PubMed ID: 17347553
[TBL] [Abstract][Full Text] [Related]
13. Impaired bone healing pattern in mice with ovariectomy-induced osteoporosis: A drill-hole defect model.
He YX; Zhang G; Pan XH; Liu Z; Zheng LZ; Chan CW; Lee KM; Cao YP; Li G; Wei L; Hung LK; Leung KS; Qin L
Bone; 2011 Jun; 48(6):1388-400. PubMed ID: 21421090
[TBL] [Abstract][Full Text] [Related]
14. Binding potency of peptide fragments of type 1 collagen cross-linked N-telopeptide measured by an enzyme-linked immunosorbant assay.
Lung FD; Chen CH; Chen HY; Liou CC; Liou YM
Protein Pept Lett; 2002 Oct; 9(5):451-7. PubMed ID: 12370034
[TBL] [Abstract][Full Text] [Related]
15. The anabolic action of intermittent PTH in combination with cathepsin K inhibitor or alendronate differs depending on the remodeling status in bone in ovariectomized mice.
Yamane H; Sakai A; Mori T; Tanaka S; Moridera K; Nakamura T
Bone; 2009 Jun; 44(6):1055-62. PubMed ID: 19303837
[TBL] [Abstract][Full Text] [Related]
16. Early changes in serum N-telopeptide and C-telopeptide cross-linked collagen type 1 predict long-term response to alendronate therapy in elderly women.
Greenspan SL; Rosen HN; Parker RA
J Clin Endocrinol Metab; 2000 Oct; 85(10):3537-40. PubMed ID: 11061497
[TBL] [Abstract][Full Text] [Related]
17. [Effects of L-threonate on bone resorption by osteoclasts in vitro].
He JH; Tong NW; Li HQ; Wu J
Sichuan Da Xue Xue Bao Yi Xue Ban; 2005 Mar; 36(2):225-8. PubMed ID: 15807273
[TBL] [Abstract][Full Text] [Related]
18. Characterization of urinary degradation products derived from type I collagen. Identification of a beta-isomerized Asp-Gly sequence within the C-terminal telopeptide (alpha1) region.
Fledelius C; Johnsen AH; Cloos PA; Bonde M; Qvist P
J Biol Chem; 1997 Apr; 272(15):9755-63. PubMed ID: 9092508
[TBL] [Abstract][Full Text] [Related]
19. Coated-tube radioimmunoassay for C-telopeptides of type I collagen to assess bone resorption.
Bonde M; Fledelius C; Qvist P; Christiansen C
Clin Chem; 1996 Oct; 42(10):1639-44. PubMed ID: 8855148
[TBL] [Abstract][Full Text] [Related]
20. Suppression of NF-kappaB activation blocks osteoclastic bone resorption during estrogen deficiency.
Strait K; Li Y; Dillehay DL; Weitzmann MN
Int J Mol Med; 2008 Apr; 21(4):521-5. PubMed ID: 18360699
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
